Chris Moore is Founder and CEO of Jura Health, a rare disease company dedicated to improving the lives of individuals with rare diseases through advanced genetic testing, comprehensive counseling, and unwavering advocacy support. Jura’s health data platform simplifies diagnostics and accelerates drug discovery, connecting patients seamlessly with disease experts and providing access to crucial genomic and clinical data.
Zachary Brooks is Founder & CEO of UGenomeAI, a biotechnology company focusing on developing genomics and bioinformatics software for personalized medicine with both research and clinical applications.
By leveraging select pharmacogenomic tools, physicians can minimize off-target effects of medications for their rare disease patients and support improved health outcomes while minimizing unintended consequences from adverse drug reactions or dosages.